Long-Term Efficacy of Risankizumab Observed for Psoriasis Regardless of Disease Characteristics

These data indicate a significant ability of this treatment to address patients’ psoriatic symptoms in a comprehensive manner, despite varying characteristics and demographics.

Related Keywords

Bruce Strober ,Yale School Of Medicine Bruce Strober ,Yale University Department ,Yale School ,Yale University ,Psoriasis Scalp Severity Index ,Nail Psoriasis Severity Index ,Palmoplantar Psoriasis Area ,Severity Index ,Limmitless ,Psoriasis ,Psoriatic Disease ,Risankizumab ,15 Year ,